{"url_path":"/fda/drug/recalls/D-0807-2026","section_key":"summary","section_title":"DRUG Recall: Baxter Healthcare Corporation — Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-08-06","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0807-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Baxter Healthcare Corporation"},"word_count":84,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0807-2026\n\n**Recalling firm:** Baxter Healthcare Corporation\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-08-06\n**Report date:** 2026-09-09\n\n## Product\nDaptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.\n\n## Reason\nCGMP Deviations\n\n## Affected lots\nLot # NC188692, Exp Date: 11/22/2027.\n\n## Distribution\nUS Nationwide; Puerto Rico; and Chile."}